8-KMaterial AgreementsOther EventsExhibits & Filings

CARDINAL HEALTH INC 8-K Report, Material Agreement (Aug 31, 2017)

Filed August 31, 2017For Securities:CAH

Summary

Cardinal Health Inc. (CAH) announced a significant expansion of its receivables financing program through a Third Amendment to its Fourth Amended and Restated Receivables Purchase Agreement. This amendment, entered into on August 30, 2017, increases the committed receivables sales facility program from $700 million to $1.0 billion. This expansion suggests a strategic move by the company to enhance its liquidity and financial flexibility by leveraging its accounts receivable more effectively. In addition to the financing update, the company also disclosed a correction to its previously filed 10-K for the fiscal year ended June 30, 2017. The error pertained to the concentration of revenue from its largest customers, where the aggregate percentage was revised from 50% to 43%. While a relatively minor adjustment in percentage, it provides a more accurate picture of customer dependency for investors evaluating the company's revenue stability.

Key Highlights

  • 1Cardinal Health's receivables financing facility has been increased from $700 million to $1.0 billion.
  • 2This expansion is achieved through a Third Amendment to the Fourth Amended and Restated Receivables Purchase Agreement.
  • 3The amendment enhances the company's liquidity and financial flexibility.
  • 4Cardinal Health corrected an error in its FY2017 10-K regarding customer revenue concentration.
  • 5The aggregate revenue from the five largest customers (including CVS and OptumRx) was revised from 50% to 43% of fiscal 2017 revenue.
  • 6The amendment was effective as of August 30, 2017.

Frequently Asked Questions

The increase in the receivables financing facility from $700 million to $1.0 billion provides Cardinal Health with greater financial flexibility and enhanced liquidity. This allows the company to access more cash by selling its accounts receivable, which can be used for working capital, investments, or other corporate purposes.

Cardinal Health amended its receivables purchase agreement to increase the size of its committed receivables sales facility program. This is a strategic decision to bolster its financing capacity and improve its ability to manage cash flow and fund operations or growth initiatives.

The company corrected an error in its fiscal year 2017 10-K report concerning the percentage of revenue derived from its five largest customers. The initial disclosure stated this was 50%, but it has been corrected to 43%.

While the percentage decreased, the corrected figure of 43% still indicates a notable concentration of revenue among its top customers. Investors should monitor this to understand potential risks associated with customer dependency, although the revised number may slightly reduce perceived concentration risk compared to the initial disclosure.